Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Exosomes & Liquid Biopsies Europe 2018

Marcin Jurga's Biography

Marcin Jurga, R&D Director, The Cell Factory bvba

Marcin Jurga, Ph.D., Doctor of Medical Sciences; M.Sc.

Marcin Jurga specializes in adult stem cells biology, extracellular vesicles (EVs), tissue engineering and regenerative medicine. Marcin Jurga graduated at Warsaw University in Poland (2002) in the field of molecular biology. In 2007 Marcin Jurga got a Ph.D. in Medical Sciences at Medical Research Institute of Polish Academy of Sciences in Warsaw, Poland with specialty in human stem cell biology and tissue engineering. The post-doc study was performed at The Newcastle University, UK and at The Institute of Cell Research Therapy Lyon, France were Marcin Jurga coordinated international research projects focused on neural, pancreatic and bone tissue engineering and was involved in preparation of clinical trial in stem cell application in pediatric neurology. Since 2011 Marcin Jurga is the head of R&D at The Cell Factory biotech company in Niel, Belgium. The Cell Factory ( focuses on development and bioproduction of new advanced medicinal products: stem cells and extracellular vesicles, and their application in regenerative medicine. Marcin Jurga is responsible for EVs products development (GLP), quality assurance, bioproduction process development (GMP) and clinical translation of the IMPs in accordance with the international regulations. Currently The Cell Factory is developing the EVs drugs: CF-MEV-107 for treatment of Crohn’s disease and CF-MEV-117 for treatment of drug resistant epilepsy. Marcin Jurga is also involved in business development and has participated in the recent deal of Esperite which secured external financing of up to EUR 13 million to support development of innovative technologies.

Marcin Jurga Image

Pre-Clinical Test Requirements For EVs Drugs

Friday, 26 October 2018 at 17:00

Add to Calendar ▼2018-10-26 17:00:002018-10-26 18:00:00Europe/LondonPre-Clinical Test Requirements For EVs DrugsExosomes and Liquid Biopsies Europe 2018 in Rotterdam, The NetherlandsRotterdam, The

Extracellular vesicles (EVs) are promising drug candidates and drug delivery tools in treatment of multiple diseases. Currently, one of the most popular source of EVs are mesenchymal stromal cells (MSCs) with a broad spectrum of anti-inflammatory and immunosuppressive activity. Translation of the EVs drug candidates into clinic requires well-established production system and effective quality control procedures. The presentation will give an overview of the clinical-grade production process of the EVs drugs and will describe the quality control and activity assays developed and validated for clinical translation of the EVs drugs.

Add to Calendar ▼2018-10-24 00:00:002018-10-26 00:00:00Europe/LondonExosomes and Liquid Biopsies Europe 2018Exosomes and Liquid Biopsies Europe 2018 in Rotterdam, The NetherlandsRotterdam, The